XML 70 R31.htm IDEA: XBRL DOCUMENT v2.4.1.9
ORGANIZATION AND PRINCIPAL ACTIVITIES (Tables)
12 Months Ended
Dec. 31, 2014
Subsidiaries of Company

As of December 31, 2014, the Company operated primarily through the following subsidiaries:

 

Name of Company

  

Place and Date of

Incorporation /

Acquisition

   Attributable
Equity Interest Held
 

Principal Activity

WuXi AppTec (BVI) Inc. (“WXAT BVI”)

  

British Virgin Islands

June 3, 2004

   100%   Holding company of People’s Republic of China(“PRC”) subsidiaries

WuXi AppTec Co., Ltd. (“WXAT”)

  

PRC

July 13, 2005

   100%   Laboratory services to pharmaceutical and biotechnology industries

WuXi AppTec (Shanghai) Co., Ltd. (“WASH”)

  

PRC

April 2, 2002

   100%   Laboratory services to pharmaceutical and biotechnology industries

Shanghai SynTheAll Pharmaceutical Co., Ltd. (“STA”)

  

PRC

January 23, 2003

   100%   Pharmaceutical manufacturing

WuXi AppTec (Suzhou) Co., Ltd. (“WASZ”)

  

PRC

October 8, 2006

   100%   Laboratory services to pharmaceutical and biotechnology industries

WuXiAppTec (Tianjin) Co., Ltd. (“WATJ”)

  

PRC

June 5, 2006

   100%   Laboratory services to pharmaceutical and biotechnology industries

WuXi AppTec Holding Company, Inc. (“AppTec Holding”)

  

United States of America (“United States” or “U.S.”)

January 3, 2008

   100%   Holding company of U.S. subsidiaries

WuXi AppTec, Inc. (“AppTec”)

  

United States

January 3, 2008

   100%   Laboratory services to biotechnology and medical device industries

WX (BVI), Ltd.

  

British Virgin Islands

July 4, 2008

   100%   Holding company of European subsidiaries

Kaipara Enterprises Ltd.

  

Cyprus

July 14, 2008

   100%   Shell company

Klivia Investments Sp. Z o.o.

  

Poland

July 31, 2008

   100%   Intermediate holding company

WuXi AppTec Biopharmaceuticals Co., Ltd. (“WABIO”)

  

PRC

May 25, 2010

   100%   Biologics manufacturing

WuXi AppTec (Wuhan) Co., Ltd. (“WAWH”)

  

PRC

November 30, 2010

   100%   Laboratory services to pharmaceutical and biotechnology industries

Shanghai AppTec (HK) Ltd.

  

Hong Kong

December 10, 2010

   100%   Shell company

Global Bond Investments Ltd.

  

Hong Kong

December 8, 2010

   100%   Investment management

Chemdepo, Inc. (“Chemdepo”)

  

United States

March 30, 2011

   100%   Radioactive chemistry compound synthesis service to pharmaceutical and biotechnology industries

WuXi AppTec UK, Inc. (“AppTec UK”)

  

United Kingdom

January 17, 2011

   100%   Sales company

WuXi AppTec Sales, LLC (“AppTec Sales”)

  

United States

January 19, 2011

   100%   Sales company

STA Pharmaceutical Hong Kong Ltd. (“STA HK”)

  

Hong Kong

April 12, 2011

   100%   Sales company

Shanghai STA Pharmaceutical R&D Co., Ltd. (“STA R&D”)

  

PRC

April 15, 2011

   100%   Pharmaceutical process development and manufacturing

WuXi PharmaTech Investment Holdings (Cayman) Inc.

  

United States

May 24, 2011

   100%   Investment holding company

WuXi PharmaTech Investments (Cayman) Inc.

  

Cayman Islands

May 24, 2011

   100%   Investment management

WuXi PharmaTech Fund I General Partner L.P.

  

Cayman Islands

May 24, 2011

   100%   Investment management

WuXi PharmaTech Investment Management (Cayman) Inc.

  

Cayman Islands

May 24, 2011

   100%   Investment management

WuXi PharmaTech Healthcare Fund I L.P.

  

Cayman Islands

May 24, 2011

   100%   Corporate venture investment (U.S. dollar fund)

Wuxi AppTec Investment & Development Co., Ltd.

  

PRC

June 29, 2011

   100%   Investment management

WuXi AppTec Biomedical Investment Management L.P.

  

PRC

July 18, 2011

   100%   Investment management

WuXi AppTec Equity Investment Management Co., Ltd.

  

PRC

August 11, 2011

   100%   Investment management

WuXi AppTec Investment Fund I L.P.

  

PRC

August 16, 2011

   100%   Corporate venture investment (RMB fund)

Abgent, Inc.

  

United States

October 14, 2011

   100%   Biologics reagent research and sales

Abgent Europe Ltd.

  

United Kingdom

October 14, 2011

   100%   Biologics reagent sales

Abgent Biotechnology (Suzhou) Co., Ltd. (“Abgent Suzhou”)

  

PRC

October 14, 2011

   100%   Biologics reagent development and production

MedKey Med-Tech Development Co., Ltd.

  

PRC

October 31, 2011

   100%   Clinical research

SynTheAll (Changzhou) Pharmaceutical R&D Co., Ltd

  

PRC

December 15, 2011

   100%   Pharmaceutical manufacturing

MedIShine Discovery, Inc.

  

PRC

December 16, 2011

   100%  

Testing services

(no activity in 2014)

WuXi AppTec (Hong Kong) Ltd.

  

Hong Kong

March 26, 2012

   100%   Sales company

WuXi AppTec (Suzhou) Testing Technology Co., Ltd.

  

PRC

May 30, 2012

   100%   Testing services

WuXi AppTec (Haimen) Co., Ltd.

  

PRC

July 2, 2012

   100%  

Pharmaceutical manufacturing

(no activity in 2014)

Changzhou SynTheAll Pharmaceutical Co., Ltd.

  

PRC

September 29, 2013

   100%  

Pharmaceutical manufacturing

(no activity in 2014)

WuXi Biologics Holdings Co., Ltd.

  

PRC

August 14, 2014

   100%   Sales company

WuXi AppTec LN (Cayman) Inc.

  

Cayman Islands

July 23, 2014

   100%   Shell company

LabNetwork B.V.

  

Netherlands

December 12, 2014

   100%   E-commerce

LabNetwork Inc.

  

United States

November 14, 2014

   100%   E-commerce

XenoBiotic Laboratories, Inc.

  

United States

September 30, 2014

   100%   Testing services

Sino Path Holdings Ltd.

  

British Virgin Islands

September 30, 2014

   100%   Sales company

XBL (BVI) Ltd.

  

British Virgin Islands

September 30, 2014

   100%   Sales company

XBL-HK, Ltd.

  

Hong Kong

September 30, 2014

   100%   Sales company

XBL-China, Inc.

  

PRC

September 30, 2014

   100%   Testing services

WuXi AppTec (Shanghai) Investment Management Co., Ltd.

  

PRC

September 19, 2014

   100%   Investment management

WuXi AppTec Lab Testing and Diagnosis (Shanghai) Co., Ltd.

  

PRC

October 17, 2014

   100%   Testing services

WuXi Genomics, Inc.

  

Cayman Islands

December 18, 2014

   100%   Investment management

WuXi Biologics (Cayman) Inc.

  

Cayman Islands

February 27, 2014

   100%   Shell company

WuXi Biologics (Hong Kong) Ltd.

  

Hong Kong

May 12, 2014

   100%   Sales company

The Company, together with its subsidiaries, is principally engaged in providing laboratory and manufacturing services to support research and development for pharmaceutical, biotechnology and medical device companies.